Usefulness of Non TNF Usage in RA Patients

Usefulness of Non TNF Usage in Rheumatoid Arthritis Patients

The aim of this study is to examine the efficacy and adverse events in the following 3 groups in rheumatoid arthritis patients:

1. Sarilumab treatment for 12 months
2. Tocilizmab treatment for 12 months
3. Abatacept treatment for 12 months

Inclusion Criteria:

・RA patients

Exclusion Criteria:

• Not RA patients
• RA patients who are allergic to the drugs, refused to do this research, or who are pregnant